Doxycycline
Approved · FDAAlso known as Acticlate, Adoxa, Alodox, Atridox+22 more
Acticlate, Adoxa, Alodox, Atridox, Avidoxy, Doryx, Doxiciclina, Doxy, Doxy Lemmon, Doxy-Caps, Doxycycline Hyclate, Mondoxyne, Monodox, Morgidox, Okebo, Oracea, Oraxyl, Periostat, Targadox, Vibra-Tabs, 6-alpha-deoxy-5-oxytetracycline, 6alpha-deoxy-5-oxytetracycline, Vibramycin, Doxycyclin, Doxycycline Monohydrate, Doxycyclinum.
Recent clinical, regulatory, research and industry developments relating to this drug.
The Role of Doxycycline in the Management of Postoperative Seromas: A Pilot Study
Effects of Treatments on the Microbiome in Healthy Volunteers and Patients With Atopic Dermatitis
Label change: DOXYCYCLINE (ANDA204234)
Label change: DOXYCYCLINE (ANDA204234)
Label change: DOXYCYCLINE (ANDA204234)
Label change: DOXYCYCLINE (ANDA207757)
Guidelines of care for the management of acne vulgaris.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Pharmacology & targets
Known molecular targets and mechanisms supported by curated pharmacology databases.
Regulatory timeline
The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.
Data from the U.S. Food and Drug Administration (U.S. Food and Drug Administration), public domain (CC0).
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Weekly Doxycycline DOT for STI Prevention Among Cisgender Women Taking HIV PrEP in Kisumu, Kenya
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- American journal of veterinary research1
- Arthritis and rheumatism1
- Contraception1
- Folia morphologica1
- JAMA1
- Journal of biomedical materials research. Part B, Applied biomaterials1
- Edelman A2
- Jensen J2
- Kaneshiro B2
- Nichols M2
- Aydin O1
- Barbieri JS1
- Barwijuk-Machała M1
- Baxter BT1
- University of Hawaii2
- Afyon Kocatepe University1
- American Academy of Dermatology1
- AO Research Institute1
- Beth Israel Deaconess Medical Center1
- Brigham and Women's Hospital1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across the same disease area as Doxycycline in the shared literature.
Studied across the same disease area as Doxycycline in the shared literature.
Studied across the same disease area as Doxycycline in the shared literature.
Studied across the same disease area as Doxycycline in the shared literature.
Studied across the same disease area as Doxycycline in the shared literature.
Studied across the same disease area as Doxycycline in the shared literature.
Studied across the same disease area as Doxycycline in the shared literature.
Studied across the same disease area as Doxycycline in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials
- Regulatory event sources are credited in the Regulatory Timeline above.